Long-acting antiretrovirals: research and implementation considerations in Africa

Affiliations

¹ Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: claire.norcross@lshtm.ac.uk.
² Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.
³ Desmond Tutu Health Foundation, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
⁴ Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
⁵ Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Global Health & Infection Department, Brighton & Sussex Medical School, Brighton, UK; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
⁶ Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Comment

Claire Norcross et al. Lancet HIV. 2023 Jul.

. 2023 Jul;10(7):e428-e429.

doi: 10.1016/S2352-3018(23)00134-0.

¹ Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: claire.norcross@lshtm.ac.uk.
² Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya.
³ Desmond Tutu Health Foundation, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
⁴ Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
⁵ Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Global Health & Infection Department, Brighton & Sussex Medical School, Brighton, UK; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
⁶ Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

No abstract available

Comment on

Long-acting antiretrovirals and HIV treatment adherence.
Nachega JB, Scarsi KK, Gandhi M, Scott RK, Mofenson LM, Archary M, Nachman S, Decloedt E, Geng EH, Wilson L, Rawat A, Mellors JW. Nachega JB, et al. Lancet HIV. 2023 May;10(5):e332-e342. doi: 10.1016/S2352-3018(23)00051-6. Epub 2023 Apr 14. Lancet HIV. 2023. PMID: 37062293 Free PMC article. Review.